Provisional Draft Agenda Biocides Working Group Meeting II March 2019

Transcription

1 Provisional Draft Agenda Biocides Working Group Meeting II March 2019 ECHA Conference Centre (Annankatu 18) Meeting room Margot Wallstrom (MW) Meeting room Guido Sacconi (GS) Meeting room Marie Curie (MC) Meeting room K325 Coffee break 11:00-11:30 Lunch break 13:00-14:00 Coffee break 15:30-16:00 11 February 2019 WG-II-2019 Tuesday 09:00-13:00 19 March 14:00-18:00 Tuesday 09:00-13:00 26 March 14:00-18:00 Wednesday 09:00-13:00 27 March 14:00-18:00 Thursday 28 March Wednesday 09:00-13:00 27 March 14:00-18:00 Thursday 09:00-13:00 28 March 14:00-18:00 Friday 09:00-13:00 29 March 14:00-16:00 APCP WG (K325) TOX WG (MW) TOX WG (MW) 09:00-13:00 TOX WG (MC - C) EFF WG (GS) EFF WG (GS) EFF WG (GS) Wednesday 10:00-13:00 EG Meeting on PT 8 (K325) 27 March 14:00-18:00 only for assigned experts Thursday 09:00-13:00 28 March 14:00-18:00 Friday 09:00-13:00 29 March 14:00-16:00 ENV WG (MC - A) ENV WG (MC - A) 1

2 Analytical methods and physico-chemical properties Working Group Item 1 - Welcome and apologies Chair: Bernhard Krebs Item 2 Administrative issues Item 3 Agreement of the agenda Item 4 Declarations of potential conflicts of interest in relation to the agenda Item 5 Agreement of the draft minutes from WG-VII-2018 WG VII 2018_APCP_5-1 WG VII 2018_APCP_5-2 WG VII 2018_APCP_5-3 WG VII 2018_APCP_5-4 WG VII 2018_APCP_5-5 Item 6 - Discussion of Union Authorisation applications 6.1 UA for product family Permethrin/S-Methoprene PT 18 Meeting document: WG II 2019_APCP_ UA for product family containing Octanoic acid Meeting document: WG II 2019_APCP_ UA for product family containing Octanoic acid/decanoic acid Meeting document: WG II 2019_APCP_ UA for product family containing Hydrogen peroxide PT Meeting document: WG II 2019_APCP_6-4 NL BE LV Item 8 - AOB 2

3 Item 1 - Welcome and apologies Efficacy Working Group Chair: Katarzyna Szymankiewicz Item 2 Administrative issues Item 3 Agreement of the agenda Item 4 Declarations of potential conflicts of interest in relation to the agenda Item 5 Agreement of the draft minutes from WG-I-2019 WG-I-2019_EFF_6-1 Item 6 - Discussion of Union Authorisation applications 6.1 UA for product family containing Hydrogen peroxide PT Meeting document: WGII2019_EFF_ UA for product family containing Octanoic acid/decanoic acid Meeting document: WGII2019_EFF_ UA for product family containing Octanoic acid Meeting document: WGII2019_EFF_ UA for product family Permethrin/S-Methoprene PT 18 Meeting document: WGII2019_EFF_6-4 Item 7 - Technical and guidance related issues LV BE NL CA 7.1 Vol. II, Parts B+C PT1-5, Appendix 4 Meeting document: WGII2019_EFF_ Vol. II, Parts B+C draft guidance PT11/12 Meeting document: WGII2019_EFF_ Vol. II, Parts B+C draft guidance PT19 Meeting document: WGII2019_EFF_7-3 ECHA 3

4 Item 8 - AOB 8.1 Outcome of e-consultations Meeting document: WGII2019_EFF_8-1 MSs 8.2 Other information & lessons learned Meeting document: WGII2019_EFF_8-2 ECHA 4

5 Item 1 - Welcome and apologies Human Health Working Group Chair: Antero Airaksinen Item 2 Administrative issues Item 3 Agreement of the agenda Item 4 Declarations of potential conflicts of interest in relation to the agenda Item 5 Agreement of the draft minutes from WG-VII-2018 WG-VII-2018_TOX_6-1 WG-VII-2018_TOX_6-2 WG-VII-2018_TOX_6-3 WG-VII-2018_TOX_6-4 WG-VII-2018_TOX_6-5 WG-VII-2018_TOX_Minutes Item 6 - Discussion of Union Authorisation applications 6.1 UA for product family containing Hydrogen peroxide PT Meeting document: WGII2019_TOX_ UA for product family containing Octanoic acid/decanoic acid Meeting document: WGII2019_TOX_ UA for product family containing Octanoic acid Meeting document: WGII2019_TOX_ UA for product family Permethrin/S-Methoprene PT 18 Meeting document: WGII2019_TOX_6-4 Item 7 - Discussion of Active Substances LV BE NL 7.1 DBNPA ED assessment Meeting document: WGII2019_TOX_7-1 DK 5

6 7.2 Sulfur dioxide generated from sulfur by combustion Meeting document: WGII2019_TOX_ Sulfur dioxide released from sodium metabisulfite PT 09 Meeting document: WGII2019_TOX_7-3 Item 8 - Technical and guidance related issues Presenter 8.1 Update on guidance development Meeting document: WGII2019_TOX_ HEAdhoc: Harmonisation of PT 2 surface disinfection exposure scenarios Meeting document: WGII2019_TOX_ HEAdhoc: PT 18 professional exposure scenarios Meeting document: WGII2019_TOX_ Dermal absorption of a repellent used together with sunscreen/sun lotion products Meeting document: WGII2019_TOX_ Harmonising the use of default dermal absorption values derived according to EFSA (2017) Meeting document: WGII2019_TOX_ Updating the WG recommendation for in situ generated active substances and their precursors Meeting document: WGII2019_TOX_8-6 UK SE 8.7 Read-across for biocides Meeting document: WGII2019_TOX_8-7 Item 9 AOB 9.1 Other information & lessons learned Meeting document: WGII2019_TOX_9-1 Presenter 9.2 Active substance workshop: Feedback and actions Meeting document: WGII2019_TOX_9-2 6

7 Item 1 - Welcome and apologies Environment Working Group Chair: Heike Schimmelpfennig Item 2 Administrative issues Item 3 Agreement of the agenda Item 4 Declarations of potential conflicts of interest in relation to the agenda Item 5 Agreement of the draft minutes from WG-VII-2018 Minutes were agreed via written procedure Item 6 - Discussion of Union Authorisation applications 6.1 UA for product family containing Hydrogen peroxide PT Meeting document: WGII2019_ENV_ UA for product family containing Octanoic acid/decanoic acid Meeting document: WGII2019_ENV_ UA for product family containing Octanoic acid Meeting document: WGII2019_ENV_ UA for product family Permethrin/S-Methoprene PT 18 Meeting document: WGII2019_ENV_6-4 Item 7 - Discussion of Active Substances LV BE NL 7.1 DBNPA ED assessment Meeting document: WGII2019_ENV_7-1 Item 8 Technical and guidance related issues 8.1 Overview on guidance to inform DK Presenter 7

8 8.2 RMM for bees (e-consultation) to inform 8.3 Report back: Workshop Extrapolation across biological level to inform 8.4 Outcome EPM project to inform 8.5 Update on ongoing EUSES projects to inform Item 9 AOB 9.1 Other information & lessons learned to inform Presenter o0o 8